Alpha Teknova

Alpha Teknova

Life Sciences Tools & Services
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

$344.7M

Market Cap • 10/23/2026

2000

(26 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

5,5

P/S

7,9

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

1,2

EPS

—

Market Cap

Market Cap

344,7M

EV

354,7M

EV/Revenue

8,1

EV/EBITDA

-37,4

EV/EBIT

-22,4

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-0,1%

Total Yield

-0,1%

Payout

0%

Retained Earnings

-143,5M

Profitability

Gross Margin

34,6%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

5,1%

Capex/Revenue

2,5%

Capex/D&A

17%

Capex/OCF

-17,2%

SBC/OCF

—

% PPE

54,8%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

3,6%

CAGR Op. Income 5Y

107,9%

CAGR Net Income 5Y

84%

CAGR EPS 5Y

-12,4%

CAGR OCF 5Y

79%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

4,5

Quick Ratio

3,3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium